A team of CRA transfer pricing consultants was engaged by a leading global medical device company to provide global transfer pricing advisory. CRA’s team has been instrumental in all parts of its transfer pricing analyses, including IP onshoring, planning, global documentation compliance, audit support, quarterly/year-end support as needed.
Drug pricing rules and tariffs reshape transfer pricing for IP
In the article “Drug Pricing Rules and Tariffs Reshape Transfer Pricing for IP,” published in Bloomberg Tax, CRA’s Transfer Pricing experts Robin Hart and ...